Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rihab Ouerghi

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
American Journal of Therapeutics|February 20, 2026
First Reported Case of Treosulfan-Induced Fixed Drug EruptionIkram Fazaa, Fatma Zgolli, Rihab Ouerghi, et al.
Hematology, Transfusion and Cell Therapy|September 28, 2024
Early bacteremia following allogeneic hematopoietic stem cell transplantation without antibiotic prophylaxis: epidemiology and antimicrobial resistanceNour Ben Abdeljelil, Rihab Ouerghi, Insaf Ben Yaiche, et al.
Expert Review of Hematology|July 16, 2024
Cyclophosphamide and horse anti-thymocyte globulin versus fludarabine, reduced cyclophosphamide and rabbit anti-thymocyte globulin conditioning regimen for allogeneic hematopoietic stem cell transplantation from matched sibling donors in patients with acquired aplastic anemiaNour Ben Abdeljelil, Insaf Ben Yaiche, Rihab Ouerghi, et al.
La Tunisie Medicale|April 8, 2026
[Allogeneic hematopoietic stem cell transplantation in children's acute myeloblastic leukemia: Survival and relapse]Nour Ben Abdeljelil, Insaf Ben Yaiche, Rihab Ouerghi, et al.
Clinical Hematology International|July 16, 2024
Total body irradiation-based conditioning versus chemotherapy before allogeneic stem cell transplantation for adults with acute lymphoblastic leukemiaNour Ben Abdeljelil, Rihab Ouerghi, Insaf Ben Yaiche, et al.
Clinical Hematology International|December 10, 2024
Role of cytomegalovirus reactivation on relapse after allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemiaSabrine Mekni, Nour Ben Abdeljelil, Rihab Ouerghi, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
American Journal of Therapeutics|February 20, 2026
First Reported Case of Treosulfan-Induced Fixed Drug EruptionIkram Fazaa, Fatma Zgolli, Rihab Ouerghi, et al.
Hematology, Transfusion and Cell Therapy|September 28, 2024
Early bacteremia following allogeneic hematopoietic stem cell transplantation without antibiotic prophylaxis: epidemiology and antimicrobial resistanceNour Ben Abdeljelil, Rihab Ouerghi, Insaf Ben Yaiche, et al.
Expert Review of Hematology|July 16, 2024
Cyclophosphamide and horse anti-thymocyte globulin versus fludarabine, reduced cyclophosphamide and rabbit anti-thymocyte globulin conditioning regimen for allogeneic hematopoietic stem cell transplantation from matched sibling donors in patients with acquired aplastic anemiaNour Ben Abdeljelil, Insaf Ben Yaiche, Rihab Ouerghi, et al.
La Tunisie Medicale|April 8, 2026
[Allogeneic hematopoietic stem cell transplantation in children's acute myeloblastic leukemia: Survival and relapse]Nour Ben Abdeljelil, Insaf Ben Yaiche, Rihab Ouerghi, et al.
Clinical Hematology International|July 16, 2024
Total body irradiation-based conditioning versus chemotherapy before allogeneic stem cell transplantation for adults with acute lymphoblastic leukemiaNour Ben Abdeljelil, Rihab Ouerghi, Insaf Ben Yaiche, et al.
Clinical Hematology International|December 10, 2024
Role of cytomegalovirus reactivation on relapse after allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemiaSabrine Mekni, Nour Ben Abdeljelil, Rihab Ouerghi, et al.
Pageof 1